A young musician who had to give up her studies after being diagnosed with ME is using her talent to help children at the ...

Norketotifen is under clinical development by Emergo Therapeutics and currently in Phase II for Unspecified Influenza Virus Infections.

After hours: January 3 at 7:58:01 PM EST Loading Chart for AIM ...

Thus a comparison of these two cases may indicate differences in the underlying pathology in ADEM (vasogenic v cytotoxic oedema) that may be crucial for estimating tissue damage and clinical outcome.

The 2004 cabinet papers are smoking-gun evidence of Howard and Costello’s wilful and damaging dithering on housing policy.